Specifically, the identification of PTBP1, H2AFZ, BCL6, and TTPAL as the regulators of osteogenic differentiation presents novel therapeutic targets for conditions such as osteoporosis and bone fracture healing. This evidence concerns the gene PTBP1 and osteoporosis.